Antivirulence agents against bacterial pathogens
Menachem Shoham
Richard G. Brennan, Maria A. Schumacher and Kim Lewis
Peter Panizzi
Mycobacterial manipulation of the host innate immune response
Cory M. Robinson
A new paradigm for genus Mycobacterium population structure
Paul Jeffrey Freidlin
Stenotrophomonas maltophilia: A world wide emerging multiple drug resistant opportunistic pathogen
Joanna S. Brooke
Hydrogen-stimulated carbon catabolism in enteric pathogens Salmonella and Shigella
Robert J. Maier, Reena Lamicchane-Khadka and Mykeshia McNorton
FOXA2 inactivation by bacterial pathogens and excessive mucus in chronic airway diseases
Gee W. Lau
Phenotypic and immunologic characteristics of Salmonella lacking RNA modification enzymes
Amin A. Fadl
Eyal Gur
Modulation of immunization via cholinergic nervous system using HI-6
Miroslav Pohanka
Turkan Sakınc
Carbon monoxide: A bactericidal molecule
B. Y. Chin
From environment to man: Is Aeromonas infection an accident or a stopover on the adaptation road?
Brigitte Lamy
Antibody orientation at bacterial surfaces has implications for both mild and severe infections
Pontus Nordenfelt
T-helper 1, T-helper 2, pro-inflammatory and anti-inflammatory cytokines in tuberculosis
Abu Salim Mustafa
Sylvie Alonso
Nermin H. Ibrahim, Azza Abdulazim Gomaa, Mohamed Ahmed Abu-Sief, Tamer M. Hifnawy and Mervat Abd El-Baseer Tohamy
Amer Hayat Khan
Min Fang
Microbial cell wall glycoconjugates as elicitors and suppressors of eukaryotic innate immunity
Antonio Molinaro
Gut microbiota regulation of host cell response as revealed using functional metagenomics
Herve M. Blottiere
Transmembrane signaling through a heme/hemophore receptor
Nadia Izadi-Pruneyre
Jong Hyun Ham
Emerging superbugs: Are ESBLs and CREs the new MRSA?
Wanda C. Reygaert
Myeloid KLF2 regulate host response to infection
Ganapati H. Mahabaleshwar
Rahul Saxena
Genetic variation in Clostridium botulinum, types of botulism in France
Michal R. Popoff
Mari-Anne Newman, Gitte Erbs and Thomas Sundelin
Laurent Guillon
New frontiers in bacteriology 2013: Biofilms, the international language of infectious diseases
John G. Thomas
The DNABII family of proteins: Diagnostic markers and therapeutic targets of bacterial biofilms
Steven D. Goodman
Microbiological environment in the lower airway of the infants and young child with cystic fibrosis
Kathryn S. Moffett
Oleg Paliy
Sarah Schmidt Grant
Two component systems and biofilm lifestyle in Pseudomonas aeruginosa
Sophie de Bentzmann
Disseminated BCG-itis in children with primary immunodeficiency
Daifulah Al Zahrani
Occurrence of feco-oral and blood borne hepatitis virus infection among children in north India
Hitender Gautam, Vikas Manchanda and Neha Sinha
The risk factors for and effects of visceral leishmaniasis in graft and renal transplant recipients
Avelar Alves da Silva
Mohammad Jahangir Hossain
Treatment of cutaneous leishmaniasis by topical application of honey
Mahasen Wadi
Joel Schwartz
Akira Kaji and Hideko Kaji
Autophagy mediated clearance of Burkholderia cenocepacia in cystic fibrosis
Benjamin T. Kopp
Neurological complications to botulinum toxin: A therapy
Anna Hristova
Does the companion diagnostics approach work for antibiotics?
Philip Onigman
The Th17 response triggered by Helicobacter pylori involves the cytokine BAFF
Marina de Bernard
Bacterial ureases and its role in long-lasting human diseases
Wieslaw Kaca, Iwona Konieczna, Marek Kwinkowski and Zbigniew Kaminski
New challenges for IFN therapy
Ahmed Lasfar
From the past to the future: Clofazimine in the treatment of MDR
Jacques H. Grosset
Helicobacter induced colitis is reversed in ?humanized? IL-10 transgenic mice
Jay H. Bream
Ayman M. Noreddin
Development of ELISA and real-time PCR for the diagnosis of strangles in horses
Sergey C. Artiushin, J. Timoney and U. Balasuriya
Yves Le Loir
Vincenza Romano, Stefano Dumontet, Federico Capuano, Donatella Nava, Anna Giannina Perugini and Vincenzo Pasquale
Within host infection dynamics in bacterial immunology and vaccine development
Pietro Mastroeni
Development of vaccines to control Chlamydia infection and disease: Are we making any progress?
Peter Timms
Bacteriophage therapy against antibiotic-resistant bacterial infections
Mzia Kutateladze
Antimicrobial peptides as novel alternative agents for treatment of infectious diseases
Margit Mahlapuu
Martin Picard
New face of an old drug: Celecoxib as an antibacterial agent
Arunasree M. Kalle
Surveillance and stewardship sense and sensibility
Yogandree Ramsamy
Genome characteristics of a Campylobacter jejuni 63A isolated from California gull excreta
Jingrang Lu, Scott P. Keely, Sharon Yelton and Nicholas Ashbolt
Impact of next generation sequencing formats on microbial genomics
Manohar R. Furtado
A bacteria strain as a model for screening the antitumor materials
Xin Mingxiu, Tang SiSi, Wang Qin, Chen Ping and Liu Chong
Antimicrobial activity of a newly synthesized methylsulfanyl-triazoloquinazoline derivatives
Rashad Al-Salahi, Mohamed Marzouk, GhadaAwad, Mohamed Al-Omar and EssamEzzeldin
Walid F. Elkhatib